Cargando…
Protein Arginine Methyltransferase 5 (PRMT5) has prognostic relevance and is a druggable target in Multiple Myeloma
Arginine methyltransferases critically regulate cellular homeostasis by modulating the functional outcome of their substrates. The protein arginine methyltransferase 5 (PRMT5) is an enzyme involved in growth and survival pathways promoting tumorigenesis. However, little is known about the biologic f...
Autores principales: | Gullà, Annamaria, Hideshima, Teru, Bianchi, Giada, Fulciniti, Mariateresa, Samur, Mehmet Kemal, Qi, Jun, Tai, Yu-Tzu, Harada, Takeshi, Morelli, Eugenio, Amodio, Nicola, Carrasco, Ruben, Tagliaferri, Pierosandro, Munshi, Nikhil C., Tassone, Pierfrancesco, Anderson, Kenneth C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871539/ https://www.ncbi.nlm.nih.gov/pubmed/29158558 http://dx.doi.org/10.1038/leu.2017.334 |
Ejemplares similares
-
PRMT5 inhibitors on the (myeloma) road
por: Gulla, Annamaria, et al.
Publicado: (2018) -
MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches
por: Amodio, Nicola, et al.
Publicado: (2018) -
Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer
por: Shailesh, Harshita, et al.
Publicado: (2018) -
Protein Arginine Methyltransferase 5 (PRMT5) Mutations in Cancer Cells
por: Rasheed, Shayaan, et al.
Publicado: (2023) -
The arginine methyltransferase PRMT5 promotes mucosal defense in the intestine
por: Hernandez, Juan E, et al.
Publicado: (2023)